Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, Palliative Research Center (PaRC), University of Pittsburgh, Pittsburgh, PA.
Emory Palliative Care Center, Emory University School of Medicine, Atlanta, GA.
JCO Oncol Pract. 2022 Apr;18(4):e504-e515. doi: 10.1200/OP.21.00573. Epub 2021 Nov 12.
Patients with advanced cancer often have unrealistic expectations about prognosis and treatment. This study assessed the effect of an oncology nurse-led primary palliative care intervention on illness expectations among patients with advanced cancer.
This study is a secondary analysis of a cluster-randomized trial of primary palliative care conducted at 17 oncology clinics. Adult patients with advanced solid tumors for whom the oncologist would not be surprised if died within 1 year were enrolled. Monthly visits were designed to foster realistic illness expectations by eliciting patient concerns and goals for their medical care and empowering patients and families to engage in discussions with oncologists about treatment options and preferences. Baseline and 3-month questionnaires included questions about life expectancy, treatment intent, and terminal illness acknowledgment. Odds of realistic illness expectations at 3 months were adjusted for baseline responses, patient demographic and clinical characteristics, and intervention dose.
Among 457 primarily White patients, there was little difference in realistic illness expectations at 3 months between intervention and standard care groups: 12.8% 11.4% for life expectancy (adjusted odds ratio [aOR] = 1.15; 95% CI, 0.59 to 2.22; = .684); 24.6% 33.3% for treatment intent (aOR = 0.76; 95% CI, 0.44 to 1.27; = .290); 53.6% 44.7% for terminal illness acknowledgment (aOR = 1.28; 95% CI, 0.81 to 2.00; = .288). Results did not differ when accounting for variation in clinic sites or intervention dose.
Illness expectations are difficult to change among patients with advanced cancer. Additional work is needed to identify approaches within oncology practices that foster realistic illness expectations to improve patient decision making.
晚期癌症患者常常对预后和治疗抱有不切实际的期望。本研究评估了肿瘤护士主导的初级姑息治疗干预对晚期癌症患者疾病期望的影响。
这是一项在 17 家肿瘤诊所进行的初级姑息治疗的集群随机试验的二次分析。研究纳入了预期在 1 年内死亡的晚期实体肿瘤成年患者。每月进行一次访视,通过了解患者对医疗的关注和目标,并授权患者及其家属与肿瘤医生就治疗方案和偏好进行讨论,以促进对疾病的现实期望。基线和 3 个月的问卷包括关于预期寿命、治疗意图和终末期疾病认知的问题。调整基线反应、患者人口统计学和临床特征以及干预剂量后,3 个月时现实疾病期望的可能性。
在 457 名主要为白人的患者中,干预组和标准护理组在 3 个月时的现实疾病期望差异不大:预期寿命分别为 12.8%和 11.4%(调整后的优势比 [aOR] = 1.15;95%置信区间 [CI],0.59 至 2.22; =.684);治疗意图分别为 24.6%和 33.3%(aOR = 0.76;95%CI,0.44 至 1.27; =.290);终末期疾病认知分别为 53.6%和 44.7%(aOR = 1.28;95%CI,0.81 至 2.00; =.288)。当考虑到诊所地点或干预剂量的变化时,结果没有差异。
晚期癌症患者的疾病期望很难改变。需要进一步努力,在肿瘤学实践中寻找促进现实疾病期望的方法,以改善患者的决策制定。